Literature DB >> 6640881

Effects of dipyridamole-induced vasodilation on myocardial uptake and clearance kinetics of thallium-201.

G A Beller, H H Holzgrefe, D D Watson.   

Abstract

Myocardial thallium-201 (201Tl) uptake and clearance after intravenous administration of dipyridamole (150 micrograms/kg) were determined in 12 open-chest anesthetized dogs with a partial coronary artery stenosis. 201Tl (1.5 mCi) was injected intravenously and myocardial biopsy specimens were obtained 10 min, 60 min, and 2 hr after injection. Serial changes in 201Tl activity in the normal zone and in the zone of partial stenosis were correlated with microsphere-determined regional blood flow and distal coronary pressure. Another nine dogs with equivalent stenosis not given dipyridamole before 201Tl served as controls. In the 12 dogs given dipyridamole, 201Tl activity at 10 min in the zone of stenosis was reduced to 42 +/- 5% of initial normal zone activity (p less than .001) and remained at 44 +/- 3% of initial normal zone activity at 2 hr. There was a good correlation (.81) between the percent reduction in myocardial 201Tl activity and the percent reduction of peak hyperemic flow as determined by measuring the percentage difference in peak coronary flow after a transient 10 sec occlusion under control and stenotic conditions. In contrast, 201Tl clearance was rapid in the normal zone, with 201Tl activity decreasing to 55 +/- 3% of initial normal zone activity by 2 hr. A redistribution pattern was produced because of the disparate clearance rates from hyperperfused and relatively hypoperfused myocardial regions. The relative 201Tl defect decreased from 58% to 11% from 10 min to 2 hr. In the normal zone dipyridamole increased epicardial flow from 1.03 +/- 0.09 (SEM) to 3.52 +/- 0.36 ml/min/g (p less than .0001) and endocardial flow from 1.19 +/- 0.09 to 2.96 +/- 0.20 ml/min/g (p = .0001). In the zone of partial stenosis the increase in epicardial flow after dipyridamole was less marked (1.01 +/- 0.10 to 1.55 +/- 0.15 ml/min/g; p = .009) and endocardial flow decreased (0.84 +/- 0.11 to 0.64 +/- 0.15 ml/min/g; p = .04). Coronary perfusion pressure distal to the stenotic zone fell from 65 +/- 3 to 50 +/- 3 mm Hg after dipyridamole. In the nine control dogs with equivalent stenosis, 201Tl uptake and washout were not significantly different in the stenotic zone compared with the normal zone. These data indicate that dipyridamole-induced vasodilation in the presence of a partial stenosis results in diminished uptake and delayed clearance compared with increased uptake and more rapid clearance in normally perfused myocardium producing an initial 201Tl defect with delayed redistribution.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6640881     DOI: 10.1161/01.cir.68.6.1328

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  Patient preparation for nuclear imaging: when should anti-ischemic medications be withheld?

Authors:  Sarkis B Baghdasarian; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

2.  Persistent chest pain following oral dipyridamole for thallium 201 myocardial imaging.

Authors:  A H Kwai; A F Jacobson; K M McIntyre; W H Williams; D E Tow
Journal:  Eur J Nucl Med       Date:  1990

3.  Dipyridamole myocardial perfusion scintigraphy.

Authors:  E H Botvinick; M Dae
Journal:  West J Med       Date:  1988-04

Review 4.  Evaluation of ischemic heart disease.

Authors:  Dipan J Shah; Han W Kim; Raymond J Kim
Journal:  Heart Fail Clin       Date:  2009-07       Impact factor: 3.179

Review 5.  Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease.

Authors:  A S Iskandrian; M S Verani; J Heo
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

Review 6.  SPECT imaging for detecting coronary artery disease and determining prognosis by noninvasive assessment of myocardial perfusion and myocardial viability.

Authors:  George A Beller; Ruth C Heede
Journal:  J Cardiovasc Transl Res       Date:  2011-07-06       Impact factor: 4.132

7.  Stress perfusion/metabolism imaging: a pilot study for a potential new approach to the diagnosis of coronary disease in women.

Authors:  B L Abramson; T D Ruddy; R A deKemp; L A Laramee; J F Marquis; R S Beanlands
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

8.  Relationship between regional myocardial blood flow and thallium-201 distribution in the presence of coronary artery stenosis and dipyridamole-induced vasodilation.

Authors:  A E Mays; F R Cobb
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

9.  Discordance between thallium-201 scintigraphy and coronary angiography in patients with Kawasaki disease: myocardial ischemia with normal coronary angiogram.

Authors:  M Fukazawa; J Fukushige; T Takeuchi; H Narabayashi; H Igarashi; T Hijii; K Ueda; Y Kuwabara; M Otsuka; Y Ichiya
Journal:  Pediatr Cardiol       Date:  1993-03       Impact factor: 1.655

10.  The effect of beta-blockers on the diagnostic accuracy of vasodilator pharmacologic SPECT myocardial perfusion imaging.

Authors:  Andrew J Yoon; Rowlens M Melduni; Shelly-Ann Duncan; Robert J Ostfeld; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2009-03-06       Impact factor: 5.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.